These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 37090051)

  • 21. Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy.
    Selva-O'Callaghan A; Labrador-Horrillo M; Solans-Laque R; Simeon-Aznar CP; Martínez-Gómez X; Vilardell-Tarrés M
    Arthritis Rheum; 2006 Oct; 55(5):791-8. PubMed ID: 17013837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
    Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
    J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
    Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
    Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of idiopathic inflammatory myopathies with novel myositis-specific autoantibodies.
    Rams A; Kosałka-Węgiel J; Kuszmiersz P; Matyja-Bednarczyk A; Polański S; Zaręba L; Bazan-Socha S
    Adv Clin Exp Med; 2021 Dec; 30(12):1239-1248. PubMed ID: 34610217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology.
    Gómez GN; Pérez N; Braillard Poccard A; Gómez RA; Costi AC; García MA; Viola M; Benitez A; Aciar MM; Crespo Espíndola M; Yucra D; Cosatti MA; Pisoni C; Capelusnik D; Lojo MN; Barrios BI; Rivero M; Kisluk B; Granel A
    Clin Rheumatol; 2021 Nov; 40(11):4473-4483. PubMed ID: 34159491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of multiple myositis-specific autoantibodies in unique patients with idiopathic inflammatory myopathy: A single centre-experience and literature review: Systematic review.
    Van Horebeek N; Vulsteke JB; Bossuyt X; Claeys KG; Dillaerts D; Poesen K; Lenaerts J; Van Damme P; Blockmans D; De Haes P; De Langhe E
    Semin Arthritis Rheum; 2021 Apr; 51(2):486-494. PubMed ID: 33831755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Idiopathic Inflammatory Myopathies in Patients With Myositis-Specific Autoantibodies.
    Casal-Dominguez M; Pinal-Fernandez I; Pak K; Huang W; Selva-O'Callaghan A; Albayda J; Casciola-Rosen L; Paik JJ; Tiniakou E; Mecoli CA; Lloyd TE; Danoff SK; Christopher-Stine L; Mammen AL
    Arthritis Rheumatol; 2022 Mar; 74(3):508-517. PubMed ID: 34480833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features.
    Sherman MA; Graf R; Sabbagh SE; Galindo-Feria AS; Pinal-Fernandez I; Pak K; Kishi T; Flegel WA; Targoff IN; Miller FW; Lundberg IE; Rider LG; Mammen AL;
    Rheumatology (Oxford); 2023 Feb; 62(SI2):SI226-SI234. PubMed ID: 35961028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.
    Laporte A; Mariampillai K; Allenbach Y; Pasi N; Donciu V; Toledano D; Granger B; Benveniste O; Grenier PA; Boussouar S
    Eur Radiol; 2022 May; 32(5):3480-3489. PubMed ID: 35022809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.
    Troyanov Y; Targoff IN; Tremblay JL; Goulet JR; Raymond Y; Senécal JL
    Medicine (Baltimore); 2005 Jul; 84(4):231-249. PubMed ID: 16010208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.
    Satoh M; Tanaka S; Ceribelli A; Calise SJ; Chan EK
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):1-19. PubMed ID: 26424665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies.
    Wong VT; So H; Lam TT; Yip RM
    Acta Neurol Scand; 2021 Feb; 143(2):131-139. PubMed ID: 32762037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies.
    Drouot L; Allenbach Y; Jouen F; Charuel JL; Martinet J; Meyer A; Hinschberger O; Bader-Meunier B; Kone-Paut I; Campana-Salort E; Eymard B; Tournadre A; Musset L; Sibilia J; Marie I; Benveniste O; Boyer O;
    Arthritis Res Ther; 2014 Feb; 16(1):R39. PubMed ID: 24484965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and immunological characteristics and prognosis of patients with autoantibody negative dermatomyositis: a case control study.
    Xing X; Gan Y; Mo W; Zhang J; Wang N; Zhang K; Ma K; Zhang L; Ma L; Lu D; Li Y; He J
    Clin Rheumatol; 2024 Mar; 43(3):1145-1154. PubMed ID: 38326675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI of skeletal muscles in patients with idiopathic inflammatory myopathies: characteristic findings and diagnostic performance in dermatomyositis.
    Ukichi T; Yoshida K; Matsushima S; Kawakami G; Noda K; Furuya K; Kurosaka D
    RMD Open; 2019; 5(1):e000850. PubMed ID: 30997152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenic mechanisms of disease in idiopathic inflammatory myopathies: autoantibodies as clues.
    Wu Y; Luo J; Duan L
    Front Immunol; 2024; 15():1439807. PubMed ID: 39281689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequencies and clinical associations of myositis-related antibodies in The Netherlands: A one-year survey of all Dutch patients.
    Platteel ACM; Wevers BA; Lim J; Bakker JA; Bontkes HJ; Curvers J; Damoiseaux J; Heron M; de Kort G; Limper M; van Lochem EG; Mulder AHL; Saris CGJ; van der Valk H; van der Kooi AJ; van Leeuwen EMM; Veltkamp M; Schreurs MWJ; Meek B; Hamann D
    J Transl Autoimmun; 2019 Dec; 2():100013. PubMed ID: 32743501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis.
    Amlani A; Choi MY; Tarnopolsky M; Brady L; Clarke AE; Garcia-De La Torre I; Mahler M; Schmeling H; Barber CE; Jung M; Fritzler MJ
    Front Immunol; 2019; 10():745. PubMed ID: 31024569
    [No Abstract]   [Full Text] [Related]  

  • 39. The Role of Myositis-Specific and Myositis-Associated Autoantibodies and the Activation of Type I Interferon Pathway in the Generation of Clinical Phenotypes of Inflammatory Myopathies.
    Skarlis C; Michalakeas N; Gerochristou M; Raftopoulou S; Marketos N; Boki K; Vassilopoulos D; Stratigos AP; Boumpas D; Mavragani C
    Mediterr J Rheumatol; 2023 Jun; 34(2):275-278. PubMed ID: 37654645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The analysis of clinical phenotypes and autoantibodies in juvenile dermatomyositis].
    Li DM; Wang L; Liu MY; Xu L; Tang XM
    Zhonghua Er Ke Za Zhi; 2020 Dec; 58(12):966-972. PubMed ID: 33256317
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.